# Study of the Use of a Single Dose of Erythropoietin to Treat Acute Myocardial Ischemia

> **NCT00524901** · PHASE2 · COMPLETED · sponsor: **University Medical Center Groningen** · enrollment: 10 (actual)

## Conditions studied

- CABG
- Coronary Artery Disease

## Interventions

- **DRUG:** Epoetin alpha
- **DRUG:** NaCl 0.9%

## Key facts

- **NCT ID:** NCT00524901
- **Lead sponsor:** University Medical Center Groningen
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-09
- **Primary completion:** 2011-01
- **Final completion:** 2011-04
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2013-02-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00524901

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00524901, "Study of the Use of a Single Dose of Erythropoietin to Treat Acute Myocardial Ischemia". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00524901. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*